Late last year, the chief leasing officer for Kilroy Realty Corp. saw more biotech companies showing interest in the second ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Scoop ...Haun Ventures, the crypto venture giant that raised $1.5 billion across two funds back near the height of the last ...

On March 23, 2025, 23andMe Holding Co. (Nasdaq: ME), a prominent genetics and biotechnology firm, announced it has ...

Alexandria Real Estate Equities has unveiled plans for a mega-project in the San Francisco Peninsula that will transform an ...

Attorneys for the San Francisco-based personal genomics and biotechnology company 23andMe filed for bankruptcy protection.

Alumis shares rose after the company signed a licensing agreement, worth $40 million in the short-term, with Tokyo-based Kaken Pharmaceutical. The stock climbed 17.9% to $4.45 on Tuesday, recovering ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with the fallout of a data breach and weak demand for its ...

The South San Francisco-based company, which pioneered at-home genetic testing, holds a trove of sensitive genetic data on ...

A Bay Area biotech company is laying off approximately 90 percent of its workforce. According to a press release, Cargo ...

Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient populationUBX1325 was ...

UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank expands ...